{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:24:15Z","timestamp":1793384655533,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:00:00Z","timestamp":1703289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.euo.2023.12.005","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T08:54:12Z","timestamp":1704358452000},"page":"697-704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3324-762X","authenticated-orcid":false,"given":"Akihiro","family":"Matsukawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Bekku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Kardoust Parizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Laukhtina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Klemm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sever","family":"Chiujdea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Fazekas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Miszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Rajwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2023.12.005_b0005","unstructured":"International Agency for Research on Cancer, World Health Organization. Global cancer observatory: GLOBOCAN 2020. https:\/\/gco.iarc.fr\/."},{"key":"10.1016\/j.euo.2023.12.005_b0010","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.eururo.2023.03.016","article-title":"A detailed evaluation of the effect of prostate-specific antigen-based screening on morbidity and mortality of prostate cancer: 21-year follow-up results of the Rotterdam section of the European Randomised Study of Screening for Prostate Cancer","volume":"84","author":"de Vos","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.12.005_b0015","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1080\/03007995.2016.1198312","article-title":"Is it time to abandon the digital rectal examination? Lessons from the PLCO cancer screening trial and peer-reviewed literature","volume":"32","author":"Cui","year":"2016","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.euo.2023.12.005_b0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0090-4295(95)96812-1","article-title":"Interexaminer variability of digital rectal examination in detecting prostate cancer","volume":"45","author":"Smith","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.euo.2023.12.005_b0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1370\/afm.2205","article-title":"Digital rectal examination for prostate cancer screening in primary care: a systematic review and meta-analysis","volume":"16","author":"Naji","year":"2018","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.euo.2023.12.005_b0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1207\/s15430154jce2003_10","article-title":"Prostate cancer screening attitudes and continuing education needs of primary care physicians","volume":"20","author":"Curran","year":"2005","journal-title":"J Cancer Educ"},{"key":"10.1016\/j.euo.2023.12.005_b0035","unstructured":"National Comprehensive Cancer Network. Prostate Cancer Early Detection. 2023."},{"key":"10.1016\/j.euo.2023.12.005_b0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.12.005_b0045","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamaoncol.2020.7456","article-title":"Population-based prostate cancer screening with magnetic resonance imaging or ultrasonography: the IP1-PROSTAGRAM study","volume":"7","author":"Eldred-Evans","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euo.2023.12.005_b0050","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa2100852","article-title":"MRI-targeted or standard biopsy in prostate cancer screening","volume":"385","author":"Eklund","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2023.12.005_b0055","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.euo.2023.12.005_b0060","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.euo.2023.12.005_b0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1148\/radiol.2016161174","article-title":"National performance benchmarks for modern screening digital mammography: update from the Breast Cancer Surveillance Consortium","volume":"283","author":"Lehman","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.euo.2023.12.005_b0070","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.euo.2023.12.005_b0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","article-title":"Random-effects model for meta-analysis of clinical trials: an update","volume":"28","author":"DerSimonian","year":"2007","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.euo.2023.12.005_b0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.euo.2023.12.005_b0085","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jnci\/dji065","article-title":"Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screening round of a randomized trial","volume":"97","author":"Andriole","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euo.2023.12.005_b0090","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0094-0143(05)70377-3","article-title":"Prostate-specific antigen as a screening test. The Netherlands experience","volume":"24","author":"Bangma","year":"1997","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.euo.2023.12.005_b0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/1097-0045(20000915)45:1<19::AID-PROS3>3.0.CO;2-M","article-title":"Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer","volume":"45","author":"Candas","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.euo.2023.12.005_b0100","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/fampra\/15.6.529","article-title":"An analysis of digital rectal examination and serum-prostate-specific antigen in the early detection of prostate cancer in general practice","volume":"15","author":"Brett","year":"1998","journal-title":"Fam Pract"},{"key":"10.1016\/j.euo.2023.12.005_b0105","first-page":"S200","article-title":"Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men","volume":"197","author":"Catalona","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2023.12.005_b0110","doi-asserted-by":"crossref","first-page":"E653","DOI":"10.1111\/j.1464-410X.2012.11398.x","article-title":"Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng\/ml","volume":"110","author":"Faria","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2023.12.005_b0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1464-410X.1994.tb16549.x","article-title":"Screening for carcinoma of the prostate: a GP based study","volume":"74","author":"Kirby","year":"1994","journal-title":"Br J Urol"},{"key":"10.1016\/j.euo.2023.12.005_b0120","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/00007611-199407000-00009","article-title":"Prostate-specific antigen and digital rectal examination in screening for prostate cancer: a community-based study","volume":"87","author":"Bretton","year":"1994","journal-title":"South Med J"},{"key":"10.1016\/j.euo.2023.12.005_b0125","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.euo.2023.09.008","article-title":"Digital rectal examination is not a useful screening test for prostate cancer","volume":"6","author":"Krilaviciute","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2023.12.005_b0130","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4321\/S0004-06142008000600019","article-title":"Patients\u2019 perceptions of pain and discomfort during digital rectal exam for prostate cancer screening","volume":"61","author":"Romero","year":"2008","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.euo.2023.12.005_b0135","first-page":"A100","article-title":"Cost analysis of screening for, diagnosing, and staging prostate cancer based on a systematic review of published studies","volume":"4","author":"Ekwueme","year":"2007","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.euo.2023.12.005_b0140","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/pros.20759","article-title":"The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer","volume":"68","author":"Gosselaar","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.euo.2023.12.005_b0145","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41391-021-00417-1","article-title":"Cancer detection rates of the PI-RADS v2.1 assessment categories: systematic review and meta-analysis on lesion level and patient level","volume":"25","author":"Oerther","year":"2022","journal-title":"Prostate Cancer Prostat Dis"},{"key":"10.1016\/j.euo.2023.12.005_b0150","doi-asserted-by":"crossref","first-page":"e059482","DOI":"10.1136\/bmjopen-2021-059482","article-title":"Prostate MRI versus PSA screening for prostate cancer detection (the MVP study): a randomised clinical trial","volume":"12","author":"Nam","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.euo.2023.12.005_b0155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/21681805.2021.1881612","article-title":"The G\u00d6TEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate","volume":"55","author":"Kohestani","year":"2021","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euo.2023.12.005_b0160","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2022.03.031","article-title":"Intensification of systemic therapy in addition to definitive local treatment in nonmetastatic unfavourable prostate cancer: a systematic review and meta-analysis","volume":"82","author":"Rajwa","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.12.005_b0165","first-page":"567","article-title":"Magnetic resonance imaging in prostate cancer detection and management: a systematic review","volume":"69","author":"Monni","year":"2017","journal-title":"Minerva Urol Nefrol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123002924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123002924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T02:16:24Z","timestamp":1721096184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931123002924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2588931123002924"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2023.12.005","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2023.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}